| 2017 |
Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Zillikens MC. Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone. December 2017;105:11-17. |
23 |
22 |
| 2019 |
Tsourdi E, Makras P, Rachner TD, Polyzos S, Rauner M, Mandanas S, Hofbauer LC, Anastasilakis AD. Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment. Bone. March 2019;120:44-49. |
3 |
3 |
| 2021 |
Butscheidt S, Tsourdi E, Rolvien T, Delsmann A, Stürznickel J, Barvencik F, Jakob F, Hofbauer LC, Mundlos S, Kornak U, Seefried L, Oheim R. Relevant genetic variants are common in women with pregnancy and lactation-associated osteoporosis (PLO) and predispose to more severe clinical manifestations. Bone. June 2021;147:115911. |
2 |
1 |
| 2022 |
Paccou J, Tsourdi E, Meier C, Palermo A, Pepe J, Body J-J, Zillikens MC. Bariatric surgery and skeletal health: a narrative review and position statement for management by the European Calcified Tissue Society (ECTS). Bone. January 2022;154:116236. |
0 |
0 |
| 2022 |
Lademann F, Tsourdi E, Hofbauer LC, Rauner M. Bone cell-specific deletion of thyroid hormone transporter Mct8 distinctly regulates bone volume in young versus adult male mice. Bone. June 2022;159:116375. |
0 |
0 |
| 2020 |
Yu EW, Tsourdi E, Clarke BL, Bauer DC, Drake MT. Osteoporosis management in the era of COVID‐19. J Bone Miner Res. June 2020;35(6):1009-1013. |
6 |
4 |
| 2020 |
Lademann F, Weidner H, Tsourdi E, Kumar R, Rijntjes E, Köhrle J, Hofbauer LC, Rauner M. Disruption of BMP signaling prevents hyperthyroidism‐induced bone loss in male mice. J Bone Miner Res. October 2020;35(10):2058-2069. |
1 |
0 |
| 2020 |
Yu EW, Tsourdi E, Clarke BL, Bauer DC, Drake MT. Reply to corticosteroid‐induced osteonecrosis in COVID‐19: a call for caution. J Bone Miner Res. October 2020;35(10):2084-2085. |
0 |
0 |
| 2021 |
Tsourdi E, Yu EW, Jan de Beur SM, Drake MT. Vaccination for coronavirus disease 2019 (COVID-19) and relationship to osteoporosis care: current evidence and suggested approaches. J Bone Miner Res. June 2021;36(6):1042-1047. |
1 |
1 |
| 2022 |
Tsourdi E. RANKL blockade for cancer cachexia: a new therapeutic opportunity? J Bone Miner Res. March 2022;37(3):379-380. |
0 |
0 |
| 2023 |
Wölfel EM, Lademann F, Hemmatian H, Blouin S, Messmer P, Hofbauer LC, Busse B, Rauner M, Jähn-Rickert K, Tsourdi E. Reduced bone mass and increased osteocyte tartrate-resistant acid phosphatase (TRAP) activity, but not low mineralized matrix around osteocyte lacunae, are restored after recovery from exogenous hyperthyroidism in male mice. J Bone Miner Res. January 2023;38(1):131-143. |
0 |
0 |